972.9 BC MSP code: Poisoning by agents primarily affecting the cariovascular system – Other and unspecified
972.9 is the BC MSP diagnostic code for “Poisoning by agents primarily affecting the cariovascular system – Other and unspecified” in BC Medical Services Plan’s September 2026 release, in effect from Sep 11, 2026.
Official description
972.9Poisoning by agents primarily affecting the cariovascular system – Other and unspecified
BC MSP diagnostic codes (ICD-9) · British Columbia
Notes for 972.9
BC Medical Services Plan’s list gives no includes, excludes or other notes for 972.9 or the headings above it.
Where 972.9 sits
- 1Valid code 972Poisoning by agents primarily affecting the cariovascular system
- 2Valid code 972.9Poisoning by agents primarily affecting the cariovascular system – Other and unspecified
Source and release
- Data release
- BC MSP · September 2026
- Effective date
- Sep 11, 2026
- Publisher
- BC Medical Services Plan
This page is built from the BC MSP catalog that Vero Codes reads when it suggests codes: BC Ministry of Health, Medical Services Plan’s September 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does BC MSP diagnostic code 972.9 mean?
972.9 is the BC MSP diagnostic code for “Poisoning by agents primarily affecting the cariovascular system – Other and unspecified” in BC Medical Services Plan’s BC MSP September 2026 release.
Where is 972.9 in BC MSP?
972.9 sits under 972 Poisoning by agents primarily affecting the cariovascular system.
What coding notes apply to 972.9?
BC Medical Services Plan’s list gives no includes, excludes or other notes for 972.9 or the headings above it.
Which BC MSP release does this page use?
It uses BC Medical Services Plan’s September 2026 release, in effect from Sep 11, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside 972.9
View 972972.0Poisoning by agents primarily affecting the cariovascular system – Cardiac rhythm regulators972.1Poisoning by agents primarily affecting the cariovascular system – Cardiotonic glycosides and drugs of similar action972.2Poisoning by agents primarily affecting the cariovascular system – Antilipaemic and antiarteriosclerotic drugs972.3Poisoning by agents primarily affecting the cariovascular system – Ganglion-blocking agents972.4Poisoning by agents primarily affecting the cariovascular system – Coronary vasodilators972.5Poisoning by agents primarily affecting the cariovascular system – Other vasodilators972.6Poisoning by agents primarily affecting the cariovascular system – Other antihypertensive agents972.7Poisoning by agents primarily affecting the cariovascular system – Antivaricose drugs, including sclerosing agents972.8Poisoning by agents primarily affecting the cariovascular system – Capillary-active drugs